DnB Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

DnB Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,394	Closed	-$413K	–	1291
2026 Q1	$413K	Sell	10,394 -2,352	-18%	-$60.2K	﹤0.01%	828
2025 Q4	$319K	Buy	12,746 +3,758	+42%	+$95.2K	﹤0.01%	695
2025 Q3	$218K	Buy	+8,988	New	+$160K	﹤0.01%	710

DnB Asset Management's CNTA Position: Q2 2026 in Review

DnB Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 10,394 shares — an estimated $413K sold.

DnB Asset Management first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $413K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

DnB Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
DnB Asset Management sold 10,394 Centessa Pharmaceuticals shares in Q2 2026, an estimated $413K.
DnB Asset Management first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
DnB Asset Management's Centessa Pharmaceuticals position peaked at $413K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.